What Researchers Did
Researchers investigated the DNA-damaging effects of hyperbaric oxygen (HBO) therapy on human leukocytes using the alkaline single cell gel test (comet assay) and formamidopyrimidine-DNA glycosylase (FPG).
What They Found
Hyperbaric oxygen therapy reproducibly induced DNA damage and significant oxidative base damage in leukocytes immediately after the first treatment. This damage was not observed 24 hours later or after subsequent treatments, suggesting an increase in antioxidant defenses. Furthermore, no DNA damage occurred when HBO treatment time was increased stepwise.
What This Means for Canadian Patients
Canadian patients undergoing HBO therapy might experience transient DNA damage, particularly after their initial treatment. However, the body appears to adapt, and a gradual increase in treatment time could potentially mitigate this effect.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or specific Canadian health contexts.
Study Limitations
The study's limitations include its focus on transient DNA damage in leukocytes and the lack of long-term follow-up or clinical correlation of these findings.